Inherited Thrombophilia and Pregnancy Complications Revisited
Authors:
- Marc A. Md RodgerMRMarc A. Md Rodger
- Michael PaidasMPMichael Paidas
- McLintock MBChB ClaireMCMcLintock MBChB Claire
- Saskia MiddeldorpSMSaskia Middeldorp
- Susan KahnSKSusan Kahn
- Ida MartinelliIMIda Martinelli
- William HagueWHWilliam Hague
- Karen Rosene MontellaKMKaren Rosene Montella
- Ian GreerIGIan Greer
- 1 August 2008
- journal article
- other
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 112 (2) , 320-324
Abstract
Inherited thrombophilias are not yet established as a cause of placenta-mediated pregnancy complications, such as fetal growth restriction, preeclampsia, abruption, and pregnancy loss. An inherited thrombophilia is only one of many factors that lead to development of these diseases and is unlikely to be the unique factor that should drive management in subsequent pregnancies. The paucity of evidence for benefit, coupled with a small potential for harm, suggests that low molecular weight heparin should be considered an experimental drug for these indications until data from controlled trials are published. At present, women with a history of placenta-mediated pregnancy complications, with or without a thrombophilia, should be followed closely without routine prophylactic low molecular weight heparin other than for prevention of venous thromboembolism in limited circumstances.Keywords
This publication has 13 references indexed in Scilit:
- Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) studyHealth Technology Assessment, 2006
- Extraembryonic expression of EPCR is essential for embryonic viabilityBlood, 2005
- The Relationship of the Factor V Leiden Mutation and Pregnancy Outcomes for Mother and FetusObstetrics & Gynecology, 2005
- Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacyBlood, 2005
- A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restrictionAmerican Journal of Obstetrics and Gynecology, 2005
- Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorderBlood, 2004
- Absence of Association of Thrombophilia Polymorphisms with Intrauterine Growth RestrictionNew England Journal of Medicine, 2002
- Prospective Evaluation of the Risk Conferred by Factor V Leiden and Thermolabile Methylenetetrahydrofolate Reductase Polymorphisms in PregnancyArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Increased Risk for Fetal Loss in Carriers of the Factor V Leiden MutationAnnals of Internal Medicine, 1999
- Pregnancy-related mortality in the united states, 1987–1990Obstetrics & Gynecology, 1996